BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26716497)

  • 1. Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups.
    Franchini M; Lippi G
    Semin Thromb Hemost; 2016 Mar; 42(2):112-7. PubMed ID: 26716497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of ABO Blood Type in Thrombosis Scoring Systems.
    Franchini M; Marano G; Vaglio S; Catalano L; Pupella S; Liumbruno GM
    Semin Thromb Hemost; 2017 Jul; 43(5):525-529. PubMed ID: 28297729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
    Jenkins PV; O'Donnell JS
    Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing.
    Franchini M
    Methods Mol Biol; 2017; 1646():43-56. PubMed ID: 28804817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO blood group and thrombotic vascular disease.
    Franchini M; Mannucci PM
    Thromb Haemost; 2014 Dec; 112(6):1103-9. PubMed ID: 25187297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
    Ward SE; O'Sullivan JM; O'Donnell JS
    Blood; 2020 Dec; 136(25):2864-2874. PubMed ID: 32785650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic Risks in Red Blood Cell Transfusions.
    Dubovoy T; Engoren M
    Semin Thromb Hemost; 2016 Mar; 42(2):102-11. PubMed ID: 26838697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO blood group and von Willebrand factor: biological implications.
    Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
    Clin Chem Lab Med; 2014 Sep; 52(9):1273-6. PubMed ID: 24945431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO blood group influences transfusion and survival after cardiac surgery.
    Welsby IJ; Phillips-Bute B; Mathew JP; Newman MF; Becker R; Rao S; Milano CA; Stafford-Smith M
    J Thromb Thrombolysis; 2014 Oct; 38(3):402-8. PubMed ID: 24935230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms.
    Akin M; Balkan C; Karapinar DY; Kavakli K
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):316-9. PubMed ID: 21949039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO blood group, hypercoagulability, and cardiovascular and cancer risk.
    Franchini M; Favaloro EJ; Targher G; Lippi G
    Crit Rev Clin Lab Sci; 2012; 49(4):137-49. PubMed ID: 22856614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raised factor VIII and ABO system as thrombotic risk factors].
    Iturbe Hernández T; Cornudella Lacasa R; Recaséns Flores V; Romero Colás MS
    Med Clin (Barc); 2002 Nov; 119(19):754-5; author reply 755. PubMed ID: 12487974
    [No Abstract]   [Full Text] [Related]  

  • 15. ABO blood groups and thrombosis: a causal association, but is there value in screening?
    Clark P; Wu O
    Future Cardiol; 2011 Mar; 7(2):191-201. PubMed ID: 21453026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cells: the forgotten player in hemostasis and thrombosis.
    Weisel JW; Litvinov RI
    J Thromb Haemost; 2019 Feb; 17(2):271-282. PubMed ID: 30618125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment.
    Garcia AA; van der Heijden JF; Meijers JC; Rosendaal FR; Reitsma PH
    J Thromb Haemost; 2006 Jun; 4(6):1418-20. PubMed ID: 16706994
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.